Investor relations
Financial calendar
Zinzino Bokslutskommuniké 2024
Zinzino Year-End Report 2024
Annualreport 2024
Årsredovisning 2024
Financial reports
Press releases
ZINZINO AB (PUBL.): ENTERS INTO AGREEMENT TO PROVIDE DIP FINANCING TO ZURVITA INITIATING CHAPTER 11 PROCESS
2024年12月21日 下午 08:00
開啟ZINZINO AB (PUBL): Zinzino announces Canary Islands as next step in its global expansion
2024年11月13日 下午 03:00
開啟ZINZINO AB (PUBL.): ZINZINO ACQUIRES 49% OF CYPRIOT OLIVE OIL PRODUCER CLEANTHI ALPHA-OLENIC LTD
2024年6月27日 上午 11:00
開啟ZINZINO AB (PUBL): LETTER OF INTENT TO ACQUIRE ZURVITA INCREASES DISTRIBUTION POWER IN NORTH AMERICA
2024年6月17日 上午 11:00
開啟ZINZINO AB (PUBL): Zinzino announces Serbia as next step in its global expansion
2024年6月11日 下午 03:30
開啟ZINZINO AB (PUBL): Zinzino now seeks acquisitions in the US and Asia to increase distribution power
2024年6月7日 下午 12:00
開啟ZINZINO AB (PUBL): Zinzino acquires assets in Xelliss – strategic reinforcement in southern Europe and in the microalgae spirulina
2024年5月12日 下午 01:00
開啟ZINZINO AB (PUBL): NOTICE OF ANNUAL GENERAL MEETING IN ZINZINO AB ON MAY 27, 2024
2024年4月26日 上午 08:00
開啟ZINZINO AB (PUBL): Zinzino and ACN, enter a strategic partnership in Europe, and in connection with it Zinzino carries out a directed new issue of B shares for SEK 10.4 million.
2024年1月29日 上午 10:00
開啟ZINZINO AB (PUBL): Zinzino changes Certified Adviser to Carnegie Investment Bank AB (publ)
2023年11月30日 上午 09:00
開啟ZINZINO AB (PUBL): Zinzino announces Mexico as next step in its global expansion
2023年9月22日 上午 08:00
開啟ZINZINO AB (PUBL.): NOTICE TO THE ANNUAL MEETING OF ZINZINO AB ON MAY 31, 2023
2023年5月2日 上午 08:00
開啟ZINZINO AB (PUBL): Zinzino launches Turkey as a next market on their road towards global expansion
2023年3月7日 下午 02:30
開啟Growing interest in personal health and customized supplements can be a great investment case
2022年11月28日 下午 02:30
開啟Zinzino announces the launch of Singapore as next step in their global expansion
2022年4月7日 上午 11:30
開啟ZINZINO AB (PUBL): Zinzino acquires brand portfolio with Swiss skincare and supplements
2022年4月6日 上午 09:30
開啟ZINZINO AB (PUBL): MEMBERS OF THE NOMINATION COMMITTEE FOR ZINZINO AB'S ANNUAL GENERAL MEETING IN 2022
2021年11月18日 下午 02:00
開啟ZINZINO AB (PUBL): Zinzino announces the launch of South Africa as next step in their global expansion
2021年11月9日 上午 11:30
開啟ZINZINO AB (PUBL): Zinzino announces launch of Taiwan as next step in the global expansion
2021年9月9日 下午 01:00
開啟ZINZINO AB (PUBL): Zinzino announces the launch of Malaysia as next step in their global expansion
2021年6月3日 上午 11:00
開啟ZINZINO AB (PUBL): A new signature BalanceOil from the pioneers of test-based nutrition
2021年4月15日 下午 03:00
開啟ZINZINO AB (PUBL): Zinzino announces the launch of India as next step in their global expansion strategy
2021年4月6日 下午 02:00
開啟ZINZINO AB (PUBL): ZINZINO MOVES TO THE PREMIER SEGMENT OF FIRST NORTH GROWTH MARKET
2020年9月16日 上午 10:00
開啟ZINZINO AB (PUBL): ONE-TIME EFFECT DUE TO CHANGED ACCOUNTING FOR DISTRIBUTOR REMUNERATION IMPROVES Q1 2020 WITH SEK 22.2 MILLION BEFORE TAX
2020年5月5日 下午 12:00
開啟ZINZINO AB (PUBL): Zinzino and Life Leadership collaborate to provide test-based nutrition to expanding markets
2019年10月25日 下午 04:40
開啟ZINZINO AB (PUBL.) APPOINTED “GROWTH COMPANY OF THE YEAR 2017” BY DIRECT SELLING SWEDEN
2018年6月1日 上午 11:00
開啟ZINZINO AB (PUBL): Q1; CONTINUED SOUND GROWTH AND STRONG PROFITABILITY IMPROVEMENT, EBITDA RISING BY 45%
2018年5月15日 上午 08:00
開啟ZINZINO AB (PUBL): STRONG GROWTH AND PROPOSAL FOR GREATLY INCREASED DIVIDENDS
2018年2月28日 上午 08:00
開啟ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FOR Q4 AND 2017 WITH PROPOSAL TO INCREASE DIVIDEND
2018年1月19日 下午 06:00
開啟Interim report, July – September 2017: IMPROVED GROSS MARGINS AND STRONG GROWTH IN THE DOMESTIC MARKET.
2017年11月13日 上午 08:30
開啟Zinzino launches groundbreaking product: BalanceOil Vegan for the heart and brain
2017年10月20日 下午 01:00
開啟Interim Report, Zinzino, April – June 2017: Very strong growth of 28% and full-scale launch of a new digital platform
2017年8月31日 上午 09:00
開啟ZINZINO LAUNCHES VIVA, A NEW DIETARY SUPPLEMENT PROMOTING BETTER SLEEP, REDUCING STRESS AND INCREASING WELL-BEING
2017年6月30日 下午 03:00
開啟Zinzino AB (publ.) appointed “Growth Company of the Year 2016” in direct sales
2017年6月2日 下午 04:00
開啟Zinzino begins selling in Switzerland ”Rich in capital and an important market”
2017年5月16日 下午 04:00
開啟Interim Report, January – March 2017: Zinzino continues to deliver strong growth and is well prepared for increased profitability
2017年5月10日 上午 09:00
開啟Zinzino taking the Omega-6/Omega-3 concept to new heights with water-miscible AquaX oil
2016年7月7日 下午 04:24
開啟Sweden's Zinzino is improving its foothold in Europe – with the establishment of operations in Germany
2016年2月22日 上午 08:00
開啟Zinzino launches Zinzino LeanShake – a nutritious meal replacement for weight control
2015年12月11日 上午 11:58
開啟Swedish Zinzino continues to grow internationally with its establishment in Canada
2015年9月17日 上午 09:28
開啟Zinzino AB (publ) acquires further 13.8 per cent of Faun Pharma AS – safeguarding continued research and expanded product range
2015年3月6日 上午 10:29
開啟The stock
Sustainability Report
Read more about our sustainability approach, targets and 2023 performance.
Greta Billing
shares@zinzino.com
+46 73 627 17 54
Fredrik Nielsen
shares@zinzino.com
+46 (0)707 900 174
Certified Adviser
All companies whose shares are to be traded on the Nasdaq First North Premier Growth Market have a certified adviser who guides and supports the company through the listing process. Subsequently, the adviser monitors that the company complies with First North's regulations for providing information to the market and investors. Carnegie Investment Bank AB (publ) is the Certified Adviser for Zinzino AB.
Certified Adviser:
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se
Why invest in Zinzino
A clear global strategy with a growth-driven, future-proof business model
Zinzino is one of Europe’s fastest-growing direct sales companies with an aggressive global expansion strategy. The Scandinavian-based health tech company is currently operating in Europe, North America, Asia, Australia, India and Africa. The overall company strategy and business model is to achieve profitable growth in new as well as existing markets. The massive growth momentum of the past decade is expected to stay constant thanks to the stability and structure of the business model in combination with top-of-the-line digital market tools as well as continuous company acquisitions.
Help improve the health of the world
Our product concept is to give health back to the world. Our goal is to get the best out of people with enthusiasm, encouragement and a great deal of energy. We are the most customer-focused direct sales company in the world. Our most important product concept, Balance, is showing continued good growth and we currently have over 500,000 test results based on blood tests in our database. We are the company that has done the most fatty acid analyses in the world.
Product development at the leading edge
Through efficient product development in-house, the company has developed a number of new products in health in which it owns its own important intellectual property rights. The newly developed products are manufactured in our own efficient production facility which means that we have 100% quality control. Zinzino’s strategy in the coming years includes continued product development at the leading edge.
Strong market position and distribution
Zinzino has strong sales organisations in its principal markets with good relationships with its customer base. The broad product portfolio attracts new customer groups and thereby generates growth. Through an updated IT platform and logistics system, Zinzino is well equipped for the expected sales growth in the coming years.
Attractive cash flow enables increased stock dividends and gives a good direct return
Zinzino’s business has a very strong cash-generating capability. Effective management of working capital combined with investments that quickly generate revenue and marginal improvements generate a strong cash flow. Thus, dividends can be distributed in accordance with the target of at least 50 per cent of the free cash flow.
分享此頁面
或複製連結